Young people with colon cancer are often misdiagnosed. 2 women share the symptoms their doctors missed.
Rates of colon cancer in people under 50 have grown in recent decades.
One study found that 82% of young colon cancer patients were misdiagnosed initially.
Two women who had colon cancer in their 30s were told they had hemorrhoids or a parasite.
Brooks Bell and Sarah Beran connected online in July 2023 over something unfortunate they had in common: they were both treated for colon cancer in their 30s after doctors misdiagnosed them. Now, they're working together to prevent others from having the same experience.
Before Beran was told in 2020 at age 34 that she had colon cancer, she chalked her fatigue up to being a working mom with two young kids. And she presumed the blood that had started appearing in her stools was caused by hemorrhoids.
"It was just a crazy time with the kids. They were so young. I was so tired all the time anyway, and I was just so busy," Beran, a stylist in LA, told Business Insider.
The most common colon cancer symptoms in people under 50 are abdominal pain, changes to bowel movements such as going more or less frequently, constipation, bloating, and diarrhea, according to a 2024 study published in JAMA Network Open. But other symptoms include blood in feces, unexplained weight loss, anemia, and vomiting for no obvious reason.
Many of these symptoms overlap with common digestive problems such as irritable bowel syndrome, which means doctors tread a tightrope when it comes to diagnosing younger, generally healthy patients. In a 2017 survey of 1,535 colon cancer survivors under 50 conducted by the Colorectal Cancer Alliance, 82% said they were initially misdiagnosed.
A 2020 survey by the charity Bowel Cancer UK of 1,073 colorectal cancer patients diagnosed under 50, and 222 people who responded on a patient's behalf, found 42% were told by doctors they were too young to develop the condition. Half of the participants didn't know they could get the disease at their age, and two thirds were initially diagnosed with conditions such as IBS, hemorrhoids, or anaemia.
It's a challenge to make sure a symptom is attributed to the correct condition without scaring people while also not overlooking the early signs of colorectal cancer, Joshua Demb, an assistant professor at the University of California, San Diego, who studies early-onset colon cancer, previously told BI.
A year into having IBS-like symptoms and needing to use the bathroom a lot more than usual, Beran's doctors sent her to a gastroenterologist who said she might have a parasite, but said it was likely nothing to worry about given her age, active lifestyle, and healthy diet.
An at-home stool test for colon cancer detected no abnormalities. What are known as fecal immunochemical tests, or FIT, are about 80% accurate, according to the University of Colorado Cancer Center.
When the bleeding got worse, Beran pushed for a colonoscopy and was diagnosed with stage 3 cancer. She said that doctors found a mass on her rectum and "over 100" polyps — small growths that are often harmless but can turn into cancer — on her colon.
"It was quite shocking to hear the word 'cancer,'" she said. "Because I was so healthy, it just wasn't something that I thought would happen to me." Growing up, Beran played sports and, before her diagnosis, she exercised almost every day. She ate plenty of fruits and vegetables, too.
Over two years, Beran was treated with 12 rounds of chemotherapy, and surgery to remove the cancerous tissues. She was given a temporary ileostomy connecting her small intestine to her abdomen to collect feces while her colon healed.
In early 2022, doctors told her the cancer had spread to her lungs, which was treated with more surgery, as well as radiation therapy.
She has been "cancer-free" for almost three years, she said.
"I feel so silly looking back on it, but who's not tired, you know what I mean?" Beran said.
While Beran was struggling with her symptoms in LA in 2019, Bell was seeking her own answers 2,500 miles away in North Carolina, after finding blood in her stool at age 38.
The former CEO's doctor told her over the phone that she likely had hemorrhoids. When the bleeding didn't stop after a few weeks, Bell's doctor examined her in person and couldn't find hemorrhoids, but said they were probably higher up in her rectum.
Sensing something wasn't right, Bell called a GI doctor without a referral, meaning it wasn't covered by her insurance. A colonoscopy revealed that she had stage 3 colon cancer, and was followed by three months of chemotherapy and surgery to remove 10 inches of her colon.
In 2024, Bell hit the five-year cancer-free mark, where the likelihood that a cancer patient will have a recurrence drops. The cancer hasn't returned, but the worry never went away.
"The treatment sucks, but the anxiety is so intense and is so persistent," she said, "you can't get away from it. It is barely tolerable."
Bell is glad she trusted her instinct, despite being told several times the blood in her stool was nothing to worry about.
"There were clues all along. You just needed to have someone who is willing to actually ask about your stool and really think about it, not shy away," she said.
Overall, thanks to screening and lifestyle changes, fewer people are developing colon cancer, according to the American Cancer Society. It estimates that in 2025, 107,320 new cases of colon cancer will be diagnosed.
But Bell and Beran are among a growing number of younger people to develop the disease. One in five colon cancer cases in 2019 were in people under 54, up from one in 10 in 1995, according to ACS data published in 2023.
The cause is unclear, but scientists have pointed to changes in the gut microbiome, antibiotic use, and environmental exposures as possible explanations.
Beran reached out to Bell online after she saw her Lead From Behind campaign, which featured Ryan Reynolds and Rob McElhenney getting colonoscopies on camera.
In July 2023, they met on Zoom and decided to combine their respective skill sets to create Worldclass, a clothing line intended to reframe colonoscopies as cool.
They sell tote bags with the irreverent slogan "colonoscopy enthusiast" printed on, and streetwear-style tracksuits stitched with the the word "ass."
In the US, people are advised to get their first colon cancer screening at 45, partly because age is a risk factor for developing polyps.
However, if someone younger has more than one symptom of colon cancer, they should consider getting a colonoscopy, Dr. James Cleary, a gastrointestinal oncologist at Dana-Farber Cancer Institute in Boston, previously told BI.
During a colonoscopy, patients are either sedated or under general anesthetic while a thin tube with a camera on the end is put in the rectum and colon to check for polyps. They must fast and take a laxative in the days before the procedure. If polyps are found, they can often be removed then and there, meaning the procedure can help prevent colon cancer.
"They're actually more like a fast, cleanse, then a nap. It's actually almost like a spa appointment," Bell said of a colonoscopy. "We could be reframing it in positive ways, where it's just a self-care wellness kind of experience."
She added: "People do not know that it's this empowering, hopeful thing that can actually protect you from this major threat."
Read the original article on Business Insider
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
11 hours ago
- Medscape
Patient Progress Notes Often ‘Fail.' They Can Be Fixed
Crafting the ideal patient progress note, at least judging from the literature, seems more easily achieved in theory than in execution. Since the late 2000s, when the electronic health record replaced pen and paper in chronicling a hospital patient's story, from entry to exit, senior physicians have struggled with house staff to make entries into the patient's record that actually mirror the patient's progress. Various articles over the past 15 years have decried the condition of these notes, finding they contained unnecessary information and many inaccuracies — primarily because the note authors had copied and pasted prior input; this keyboard capability has been dubbed an 'egregious danger.' 'These notes not only fail to reflect the orderly progression of thought and action…but also rarely provide clear documentation of the day's events,' authors of one study in The American Journal of Medicine wrote in 2009. About 5 years ago, the American College of Physicians chimed in: 'At present, it is far too easy to open a patient chart, read volumes of data, and find that no single person has stated what they believe is happening.' Other articles have attempted to create audit tools or best practice recommendations. ('Pulling in a full list of current medications is unlikely to improve the value of the note and may become outdated quickly depending on the timing of when a note is written.') In 2019, JAMA Network Open published a California hospitals-based study that showed the significant disconnect between the number and type of exams that a group of nine emergency department trainees recorded as having completed and the actual number and type of exams that 12 observers witnessed either via direct audiovisual observation or by a review of the recorded observation. The agreement between what was actually recorded and observed was barely 50%. The observers, however, jibed with each other 90% of the time. Contributing to the progress notes' bloat factor is how the hospitals use them, namely for coding, billing, and quality reporting. These entries make them legal documents and therefore the justified recipient of all non-care patient information. This extra information often obfuscates the point of the note's existence. And it most likely negatively affects the person in the bed. 'Poor notes negatively impact patient care,' wrote the authors of a new study conducted at Johns Hopkins, Baltimore, and published in the Journal of General Internal Medicine . Bottom line: It is finding the right balance — combining seasoned staff's clinical experience with the nearly innate tech know-how of incoming juniors — that has continued to elude all. Creating Readable, Usable Progress Notes Refusing to accept that, Johns Hopkins' Samuel Durso, MD, MBA, executive vice chair, Department of Medicine, Johns Hopkins University, and director, Department of Medicine, Johns Hopkins Bayview Medical Center, decided on a new tack for his study. He said in a recent interview that he had had enough of seeing poorly devised notes. Samuel Durso, MD, MBA 'Most of the time, you can't tell what is going on,' said Durso. The Durso team took a different path for getting seasoned hospitalists to create readable, usable patient progress notes. They created a rubric with 15 gradable items, devised an educational intervention that was used when necessary, and included a control group. The total number of hospitalist participants was 26. The participants were all about 40 years old and had worked in hospital medicine for an average of about 9 years. The study team rated 156 of the study participants' notes, taken 6 months prior to the educational instruction and after. The creation of the rubric was based on a literature review, 100 progress notes, the team's assessment of existing admissions notes, and peer feedback. The study results showed that progress-note quality improved if hospital physicians were guided via the rubric. P -value scores were significant in 8 of the 15 graded items. Hospital physicians do not deliberately create poor progress notes, Durso said. 'It's not because people are stupid or lazy; it's because hospital systems are set up a certain way,' he said. As for what happens next, Durso said he is thinking about ways to maintain gains from the study results by 'baking' them into the actual workday. 'We don't have that answer yet,' he said. 'It takes people to do this and train them.' One option could be to use Johns Hopkins' existing artificial intelligence software to incorporate note quality. He addressed the size of his study. 'We didn't need this study to tell us we have a problem,' he said. His team wanted to see if it could design a plan that was workable in the Johns Hopkins environment 'to give us an indication of whether the teaching method is effective.' The study also provided the methodology some credibility. 'At least what we have shown is we can train people to improve their notes, with adjudication between observers.'
Yahoo
2 days ago
- Yahoo
WSU study finds possible link between childhood obesity and mothers' smoking pre-pregnancy
A study led by Washington State University (WSU) has identified possible links between childhood obesity and whether a mother smoked before pregnancy. The study found body mass index (BMI) patterns that could predict obesity, with findings published in Jama Network Open. The research analyzed the BMI trajectories of over 9,400 children, finding that while most children follow a typical BMI development path, 11% showed atypical patterns linked to factors before pregnancy. 'The most distinct finding is that we can identify children on a path to obesity as early as age 3.5 years,' said Chang Liu, an assistant professor of psychology at WSU and the corresponding author of the new paper. The study used data from the Environmental Influences on Child Health Outcomes (ECHO) program, covering from January 1997 to June 2024. Children in the atypical BMI group were more likely to have mothers who smoked during pregnancy or had high pre-pregnancy BMI, according to a release from WSU. The study said these children did not experience the typical BMI decline after their first year and began rapid weight gain by age 3.5, reaching an average BMI above the 99th percentile by age 9. The study highlights the potential for early intervention, suggesting that identifying at-risk children by age 3.5 could help prevent obesity and its associated health risks. The findings underscore the importance of early identification and intervention in preventing childhood obesity, with prenatal factors playing a significant role in determining BMI trajectories.
Business Insider
3 days ago
- Business Insider
Cofounder of Neuralink rival Precision Neuroscience reveals what people often get wrong about brain implants
At least that's the line from Dr. Ben Rapoport, the cofounder and chief science officer of Precision Neuroscience, a brain-computer interface, or BCI, company. "Many people have the impression that the data that we care about is sort of everywhere inside this dimensional structure," Rapoport, a neurosurgeon and engineer, told Business Insider. That's a big misconception, he said. People often incorrectly assume that "you need electrodes that penetrate deep inside the brain to get that information out," he added. But brain implants don't need to be as invasive as they might sound, he said. Precision is developing a thin film that sits on the brain and records brain activity in patients with paralysis. "We implant modules of 1,024 electrodes on the brain surface in the area that controls movement, especially the hand," Rapoport said. That allows them to have cursor control, typing ability, access the internet, use PowerPoint, play games, and word process, he added. These are actions that require vision, movement, sensation, and executive function — core parts of consciousness that are concentrated in the brain's outermost layer, the cortex, Rapoport said. Deeper inside are "connections, you know, between those activities and also sort of subconscious processes, because the brain coordinates a lot of activities in the body that don't take place consciously," he added. The New York-based startup, which received FDA clearance for part of its wireless brain-computer interface in April, has raised $155 million in funding since it launched in 2021. It is one of a few companies advancing this technology as part of the Implantable BCI Collaborative Community. BCIs are largely classified into two categories: invasive and non-invasive. Non-invasive BCIs, which don't require surgery, often rely on external sensors to detect the electrical signals in the brain. BCS that are implanted record neural activity directly from the brain and are being developed to restore speech, movement, and other complex functions in people with neurological conditions. The buzziest BCI these days is Elon Musk's Neuralink, which has ambitions to create a "symbiosis" between the human brain and AI. But there are a host of other companies working on BCIs as a way to treat neurological diseases, like Precision Neuroscience. The company has tested its temporary device in over forty patients in early clinical studies. Over the next year, it will prepare for the first human studies of its permanently implanted devices. "There are certain internal validation checks and internal milestones that we need to meet for ourselves and for the FDA before we want to start implanting the permanently implanted wireless device in humans," Rapoport said. The company's ultimate goal is to help paralyzed people get "back to a level of functional capacity where they can be significantly independent, economically self-sufficient, and hold a job in the workplace," Rapoport said. Correction: June 27, 2025 — An earlier version of this story said that Dr. Ben Rapoport was the founder and CEO of Precision Neuroscience; Dr. Rapoport is the cofounder and chief science officer. An earlier version also mischaracterized the film that goes on the brain. It is not studded with electrodes; the electrodes are embedded.
